paper-with-me

Papers

Disease Progression Timeline Estimation for Alzheimer's Disease using Discriminative Event Based Modeling

2018-08-10 · Vikram Venkatraghavan, Esther E. Bron, Wiro J. Niessen, Stefan Klein, for the Alzheimer's Disease Neuroimaging Initiative

Alzheimer's Disease (AD) is characterized by a cascade of biomarkers becoming abnormal, the pathophysiology of which is very complex and largely unknown. Event-based modeling (EBM) is a data-driven technique to estimate the sequence in which biomarkers for a disease become abnormal based on cross-sectional data. It can help in understanding the dynamics of disease progression and facilitate early diagnosis and prognosis. In this work we propose a novel discriminative approach to EBM, which is shown to be more accurate than existing state-of-the-art EBM methods. The method first estimates for each subject an approximate ordering of events. Subsequently, the central ordering over all subjects is estimated by fitting a generalized Mallows model to these approximate subject-specific orderings. We also introduce the concept of relative distance between events which helps in creating a disease progression timeline. Subsequently, we propose a method to stage subjects by placing them on the estimated disease progression timeline. We evaluated the proposed method on Alzheimer's Disease Neuroimaging Initiative (ADNI) data and compared the results with existing state-of-the-art EBM methods. We also performed extensive experiments on synthetic data simulating the progression of Alzheimer's disease. The event orderings obtained on ADNI data seem plausible and are in agreement with the current understanding of progression of AD. The proposed patient staging algorithm performed consistently better than that of state-of-the-art EBM methods. Event orderings obtained in simulation experiments were more accurate than those of other EBM methods and the estimated disease progression timeline was observed to correlate with the timeline of actual disease progression. The results of these experiments are encouraging and suggest that discriminative EBM is a promising approach to disease progression modeling.

📄 PDF Abstract BibTeX arXiv:1808.03604

Code (1)

88vikram/pyebm 공식 구현

Tasks

Prognosis

Methods 이 논문이 사용한 방법론

EBM 설명 없음

Similar Papers 제목 키워드 기반

Data-Driven Disease Progression Modelling

2022-11-01 · Neil P. Oxtoby

Intense debate in the Neurology community before 2010 culminated in hypothetical models of Alzheimer's disease progression: a pathophysiological cascade of biomarkers, each dynamic for only a segment of the full disease …

Analyzing the effect of APOE on Alzheimer's disease progression using an event-based model for stratified populations

2020-09-15 · Vikram Venkatraghavan, Stefan Klein, Lana Fani, Leontine S. Ham 외

Alzheimer's disease (AD) is the most common form of dementia and is phenotypically heterogeneous. APOE is a triallelic gene which correlates with phenotypic heterogeneity in AD. In this work, we determined the effect of …

A Discriminative Event Based Model for Alzheimer's Disease Progression Modeling

2017-02-21 · Vikram Venkatraghavan, Esther Bron, Wiro Niessen, Stefan Klein

The event-based model (EBM) for data-driven disease progression modeling estimates the sequence in which biomarkers for a disease become abnormal. This helps in understanding the dynamics of disease progression and facil…

Probabilistic Event Cascades for Alzheimer's disease

2012-12-01 · NeurIPS 2012 12 · Jonathan Huang, Daniel Alexander

Accurate and detailed models of the progression of neurodegenerative diseases such as Alzheimer's (AD) are crucially important for reliable early diagnosis and the determination and deployment of effective treatments. I…

Learning the progression and clinical subtypes of Alzheimer's disease from longitudinal clinical data

2018-12-03 · Vipul Satone, Rachneet Kaur, Faraz Faghri, Mike A. Nalls 외

Alzheimer's disease (AD) is a degenerative brain disease impairing a person's ability to perform day to day activities. The clinical manifestations of Alzheimer's disease are characterized by heterogeneity in age, diseas…

BIG-bench Machine Learning